000 | 01820 a2200505 4500 | ||
---|---|---|---|
005 | 20250514165521.0 | ||
264 | 0 | _c20040322 | |
008 | 200403s 0 0 eng d | ||
022 | _a0006-8993 | ||
024 | 7 |
_a10.1016/j.brainres.2003.10.058 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBlock, F | |
245 | 0 | 0 |
_aAssociation between inflammation and nigral neuronal damage following striatal excitotoxic lesion. _h[electronic resource] |
260 |
_bBrain research _cFeb 2004 |
||
300 |
_a29-35 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBrain Diseases _xmetabolism |
650 | 0 | 4 | _aCell Count |
650 | 0 | 4 |
_aChondroitin Sulfate Proteoglycans _xmetabolism |
650 | 0 | 4 |
_aCorpus Striatum _xinjuries |
650 | 0 | 4 |
_aDizocilpine Maleate _xpharmacology |
650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
650 | 0 | 4 | _aFunctional Laterality |
650 | 0 | 4 |
_aGlial Fibrillary Acidic Protein _xmetabolism |
650 | 0 | 4 |
_aImmunohistochemistry _xmethods |
650 | 0 | 4 |
_aInflammation _xchemically induced |
650 | 0 | 4 |
_aKeratan Sulfate _xmetabolism |
650 | 0 | 4 | _aLumican |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aPhosphopyruvate Hydratase _xmetabolism |
650 | 0 | 4 |
_aQuinolinic Acid _xtoxicity |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aRolipram _xpharmacology |
650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
700 | 1 | _aLoos, M | |
700 | 1 | _aFrohn, C | |
700 | 1 | _aSchwarz, M | |
773 | 0 |
_tBrain research _gvol. 998 _gno. 1 _gp. 29-35 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.brainres.2003.10.058 _zAvailable from publisher's website |
999 |
_c14452553 _d14452553 |